Athersys (ATHX) Tops Q2 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PCVX
3. SPY
4. ATH
5. PTC
6. CME
7. USO
8. AMD
9. EVTL
10. KLC

Go back to Athersys (ATHX) Tops Q2 EPS by 3c

Athersys Reports Second Quarter 2015 Results

August 6, 2015 4:05 PM EDT

CLEVELAND, Aug. 06, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) today announced its financial and operating results for the three months ended June 30, 2015.

Highlights of the second quarter of 2015 and recent events include:

Completed additional analyses of data from Phase 2 clinical study of MultiStem® therapy to treat ischemic stroke further demonstrating the potential benefit to patients who receive MultiStem treatment within 36 hours of stroke, as described below;Advanced launch activities for grant-supported Phase 2 clinical study to evaluate the administration of MultiStem cells to patients who have suffered a severe, non-ST-elevated... More